📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

MYBL2 mRNA expression as a potential biomarker of therapeutic response to genotoxic treatments in myelodysplastic syndrome. (2018)

First Author: Bayley R

Attributed to: Engaging and creating “Influencers” within an academic-industry environment funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.18632/oncotarget.26477

PubMed Identifier: 30680058

Publication URI: http://europepmc.org/abstract/MED/30680058

Type: Journal Article/Review

Volume: 9

Parent Publication: Oncotarget

Issue: 101

ISSN: 1949-2553